Options
急性骨髓性白血病病人化學治療期間因感染再入院之相關因素分析
Date Issued
2026
Author(s)
張維紛
WEI-FEN,JHANG
Advisor
白香菊
Abstract
研究背景:初次診斷急性骨髓性白血病(Acute Myeloid Leukemia,AML)患者在接受高強度化療後,導致免疫功能低下。化學治療期間常伴隨骨髓抑制等相關副作用,造成白血球、血紅素及血小板低下,此期間感染風險顯著增加,可能導致病人非預期的再入院,然而,影響感染發生之相關因素尚未明確,有待進一步探討。研究目的:本研究目的為探討初次診斷急性骨髓性白血病(AML)患者於化學治療期間因感染而再入院的相關因素。研究方法:本研究採回溯性嵌入型病例對照研究法(nested case-control study),於北部某醫學中心血液腫瘤科病房進行,資料收集期間為2014年1月至2024年11月。收集初次診斷急性骨髓性白血病(AML)執行化學治療病人為研究對象,採取病例(非預期感染再入院):對照(預期治療入院)比例為1:1之抽樣。資料分析以SPSS統計套裝軟體進行,包括描述性分析、獨立樣本t檢定、皮爾森卡方檢定、費雪精確檢定及邏吉斯迴歸分析等。研究結果:本研究共納入182名患者(病例組91名、對照組91名)。病例組平均再入院時間為7.12 ± 4.1天,顯著短於對照組之21.42 ± 7.65天(p < 0.001)。多變量邏吉斯迴歸分析顯示,化療前血小板數較低(OR = 0.67,95% CI: 0.51 – 0.88,p = 0.004)、INR偏高(OR = 1.77,95% CI: 1.17 – 2.68,p = 0.007)、白蛋白偏低(OR = 0.55,95% CI: 0.33 – 0.92,p = 0.022)及發生口腔黏膜炎(OR = 9.27,95% CI: 3.79 – 22.70,p < 0.001)為感染再入院之獨立相關因素。ROC分析顯示化療前 CRP 以 1.63 mg/dL為最佳截斷值,敏感度 51.1%,特異度達 83.1%(AUC = 0.65)。研究結論:血小板數、INR、白蛋白及口腔黏膜炎為AML患者化療後感染再入院之獨立相關因素。臨床護理人員應針對上述高風險指標建立標準化的出院前評估機制,並加強出院後7至10天內的追蹤,以降低感染再入院之發生率,提升照護品質。
Background: Patients newly diagnosed with acute myeloid leukemia (AML) who undergo intensive chemotherapy often experience immunosuppression. Bone marrow suppression leads to decreased white blood cells, hemoglobin, and platelets, resulting in a significantly increased risk of infection and possible unplanned hospital readmissions. However, the specific factors that contribute to infection-related readmissions remain incompletely understood.Objective: This study aimed to investigate factors associated with hospital readmissions due to infections in patients newly diagnosed with AML during chemotherapy treatment.Methods: A nested retrospective case-control study was conducted at a medical center in northern Taiwan from January 2014 to November 2024. A 1 : 1 sampling ratio compared cases (unplanned infection-related readmissions) with controls (planned treatment admissions). Data analysis included descriptive statistics, independent t-tests, chi-square tests, Fisher's exact test, and logistic regression.Results: A total of 182 patients were enrolled (91 cases, 91 controls). The mean readmission time was 7.12 ± 4.1 days in the case group vs 21.42 ± 7.65 days in the controls (p < 0.001). Multivariate logistic regression identified a lower platelet count (OR = 0.67, 95% CI: 0.51 – 0.88), higher INR (OR = 1.77, 95% CI: 1.17 – 2.68), lower albumin (OR = 0.55, 95% CI: 0.33 – 0.92), and oral mucositis (OR = 9.27, 95% CI: 3.79 – 22.70) as independent factors (all p < 0.05). ROC analysis revealed an optimal pre-chemotherapy CRP cut-off of 1.63 mg/dL, with sensitivity 51.1% and specificity 83.1% (AUC = 0.65, 95% CI: 0.56 – 0.73).Conclusion: Platelet count, INR, albumin, and oral mucositis are independent factors associated with infection-related readmission in patients with AML. Standardized pre-discharge assessments targeting these indicators and intensive post-discharge surveillance are recommended within 7–10 days to reduce infection-related readmissions.
Subjects
急性骨髓性白血病
感染再入院
口腔黏膜炎
白蛋白
嵌入型病例對照研究
Acute myeloid leukemia
infection-related readmission
oral mucositis
albumin
nested case-control study
Type
thesis
File(s)
No Thumbnail Available
Name
114CSMU0563011-004.pdf
Size
1.47 MB
Format
Adobe PDF
Checksum
(MD5):37457df9e11fd766917c21f67ff5c581